Flaxseed / Flaxseed Oil (Linum usitatissimum)
Flaxseed (linseed) is a rich plant source of alpha-linolenic acid (ALA, a plant omega-3), with USDA data listing about 22.8 g per 100 g of seed, along with lignans (plant compounds thought to have weak estrogen-like effects) and soluble fiber. In people it has been studied mainly for blood cholesterol and blood pressure, where pooled analyses of randomized trials found small reductions with whole or ground seed, while flaxseed oil did not lower cholesterol. Pooled trials also found small drops in fasting blood sugar and insulin with whole seed, but not with the oil or lignan extracts. A 188-woman placebo-controlled trial found a lignan-rich flaxseed bar did not reduce hot flashes. Ground flaxseed provides all three components; flaxseed oil provides ALA but not lignans or fiber. Flaxseed is a food, not a treatment for any disease.
Benefits
Cholesterol and blood pressure
A meta-analysis of 28 trials found whole or ground flaxseed slightly lowered total and LDL cholesterol, while flaxseed oil had no significant effect; a 26-week oil trial found no LDL change. Pooled trials found blood pressure fell under 3 mmHg on average. In a 6-month trial in adults with peripheral artery disease, 30 g a day of milled seed lowered systolic pressure about 10 mmHg versus placebo, mainly in those starting at 140 mmHg or above.
Blood sugar and insulin sensitivity
A meta-analysis of 25 randomized trials found small drops in fasting blood sugar, insulin and insulin resistance with whole flaxseed, but not with flaxseed oil or lignan extract, and no significant change in HbA1c. In adults with prediabetes, 13 g a day of ground seed lowered glucose and insulin versus none, but 26 g did not lower insulin. Flaxseed does not replace diabetes care.
Lignans and menopausal hot flashes
Gut bacteria convert flaxseed lignans into enterolignans, plant compounds thought to have weak estrogen-like effects. In a randomized double-blind trial in 188 postmenopausal women, a daily flaxseed bar providing 410 mg of lignans for 6 weeks did not reduce hot flashes more than a placebo bar (P = 0.29). No study cited here shows a hormonal benefit.
Plant omega-3 (ALA) intake and blood levels
Flaxseed is a rich plant source of ALA, with about 22.8 g per 100 g of seed in USDA data. In controlled trials, eating ground or milled flaxseed every day raised blood ALA levels compared with control foods. ALA from flaxseed oil did not change blood fat levels in a 26-week placebo-controlled trial.
Mechanism of action
ALA intake and blood vessel effects
ALA is the main fat in flaxseed. In the 6-month milled flaxseed trial, blood ALA rose with flaxseed and blood ALA levels correlated with systolic and diastolic pressure. This is a correlation within one trial; how ALA might act on blood vessels is not settled.
Lignan conversion to enterolignans
Flaxseed lignans, mainly secoisolariciresinol diglucoside (SDG), are converted by gut bacteria to enterodiol and enterolactone. Urinary enterolignans rose sharply with a lignan supplement, and blood enterolignans rose with milled flaxseed, where they correlated with changes in diastolic pressure. Lignans are thought to have estrogen-like and anti-estrogen effects, but the hot flash trial was negative.
Fiber and the whole seed versus oil difference
Pooled trials found whole or ground flaxseed lowered LDL cholesterol and blood sugar markers while flaxseed oil did not, which points to parts of the seed other than ALA, such as fiber and lignans. Binding of bile acids by the seed's soluble fiber is a proposed explanation that the trials cited here did not test.
Clinical trials
Meta-analysis of 28 randomized controlled trials of flaxseed, flaxseed oil or lignan supplements in adults, published 1990 to 2008. Flaxseed oil had no significant effect on total or LDL cholesterol, and HDL cholesterol and triglycerides did not change. (Pan et al. 2009, Am J Clin Nutr)
Adults across 28 randomized trials.
All flaxseed forms together lowered total and LDL cholesterol by 0.10 and 0.08 mmol/L. Whole flaxseed lowered them by 0.21 and 0.16 mmol/L and lignan supplements by 0.28 and 0.16 mmol/L. Effects were larger in women, especially postmenopausal women, and in people with high starting cholesterol.
Systematic review and meta-analysis of 15 randomized controlled trials (19 treatment arms) of flaxseed powder, oil or lignan extract. Systolic pressure did not fall significantly with oil or lignan extract, and the effect in trials shorter than 12 weeks was not significant. (Ursoniu et al. 2016, Clin Nutr)
1302 participants across 15 trials.
Flaxseed products lowered systolic blood pressure by 2.85 mmHg and diastolic by 2.39 mmHg versus control. Flaxseed powder lowered both; flaxseed oil lowered diastolic but not systolic pressure; lignan extract lowered neither.
Prospective, double-blind, placebo-controlled randomized trial. Participants ate foods containing 30 g of milled flaxseed or placebo foods every day for 6 months. (Rodriguez-Leyva et al. 2013, Hypertension)
110 adults with peripheral artery disease.
After 6 months, systolic blood pressure was about 10 mmHg and diastolic about 7 mmHg lower with flaxseed than with placebo. In those starting at 140 mmHg or above, systolic pressure fell 15 mmHg. Blood ALA and enterolignans rose 2- to 50-fold with flaxseed, and body weight did not differ between groups.
Double-blind randomized controlled trial. Men and postmenopausal women on a low-fat diet ate baked goods with 40 g/day of ground flaxseed or matching wheat bran products for 10 weeks. Inflammation and oxidative stress markers did not change. NIH-funded. (Bloedon et al. 2008, J Am Coll Nutr)
62 adults with LDL cholesterol of 130 to 200 mg/dL.
Compared with wheat bran, flaxseed lowered LDL cholesterol 13 percent at 5 weeks, but the 7 percent drop at 10 weeks was not significant. At 10 weeks, Lp(a) fell 14 percent and HOMA-IR insulin resistance fell 23.7 percent. In men, HDL fell 16 percent at 5 weeks.
Randomized double-blind trial of 3 g/day of ALA from flaxseed oil capsules versus olive oil placebo capsules for 26 weeks. Changes in LDL, HDL and triglycerides did not differ between groups, and adjusted total cholesterol was higher with flaxseed oil (P = 0.026). (Harper et al. 2006, J Nutr)
56 participants (31 flaxseed oil, 25 olive oil).
Flaxseed oil did not improve any measured blood fat concentration or particle size compared with olive oil after 26 weeks. The authors concluded that ALA from flaxseed oil does not alter these measures.
Systematic review and meta-analysis of 25 randomized placebo-controlled trials (30 treatment arms) of whole flaxseed, flaxseed oil or lignan extract, searched to November 2016. HbA1c did not change, and flaxseed oil and lignan extract showed no significant effects. (Mohammadi-Sartang et al. 2018, Nutr Rev)
Adults across 25 randomized trials.
Flaxseed lowered fasting blood glucose by 2.94 mg/dL, insulin by 7.32 pmol/L and HOMA-IR by 0.49, and raised an insulin sensitivity index. These effects were seen only with whole flaxseed, and the insulin effects only in trials lasting 12 weeks or more.
Randomized crossover trial. Participants ate 0, 13 or 26 g/day of ground flaxseed for 12 weeks each as part of their usual diet. Fructosamine, C-reactive protein, adiponectin and IL-6 did not differ between periods. (Hutchins et al. 2013, Nutr Res)
25 overweight or obese men and postmenopausal women with prediabetes.
Glucose, insulin and HOMA-IR differed by treatment. Glucose fell with 13 g compared with 0 g. Insulin and HOMA-IR fell with 13 g but not with 26 g or 0 g, so the higher amount did not add benefit.
Randomized, double-blind, placebo-controlled crossover trial of 360 mg/day of flaxseed lignan for 12 weeks per period, with an 8-week washout, in people with type 2 diabetes and mildly high cholesterol. Fasting glucose, insulin, insulin resistance and blood lipids did not change significantly. Funded by Chinese government science grants; Frutarom Netherlands and Jarrow Formulas donated the study capsules. (Pan et al. 2007, PLoS One)
68 adults with type 2 diabetes who completed the study.
HbA1c changed by -0.10 percent with the lignan supplement versus +0.09 percent with placebo (P = 0.001), a small difference. Urinary enterolignans rose sharply with the supplement.
Randomized, double-blind, placebo-controlled phase III trial. Women ate one bar a day for 6 weeks holding 7.5 g of flaxseed that provided 410 mg of lignans, or a placebo bar with the same fiber content, and kept daily hot flash diaries. Supported in part by US Public Health Service grants from the National Cancer Institute; Glanbia Nutritionals supplied both bars. (Pruthi et al. 2012, Menopause)
188 postmenopausal women with hot flashes, with or without a history of breast cancer.
Hot flash scores fell by 4.9 with flaxseed and 3.5 with placebo (P = 0.29), a difference that was not significant, and slightly more than a third of women in each group had a 50 percent drop. Both groups reported bloating, gas, diarrhea and nausea, likely from the fiber in both bars. The authors concluded the results do not support flaxseed lignans for hot flashes.
Side effects and drug interactions
Common Potential side effects
Important Drug interactions
Frequently asked questions about Flaxseed / Flaxseed Oil (Linum usitatissimum)
What is the recommended dosage of Flaxseed / Flaxseed Oil?
There is no official dose. Trials of ground or milled seed used 13 to 40 grams a day: 30 grams a day for 6 months in the blood pressure trial, 40 grams a day in baked goods in a cholesterol trial, and 13 grams a day in a prediabetes trial, where 26 grams did not work better. A flaxseed oil trial used 3 grams of ALA a day in capsules. NCCIH notes higher doses may cause bloating, fullness and diarrhea, and advises talking with your health care provider first if you take any medicine.
What is Flaxseed / Flaxseed Oil used for?
Flaxseed provides ALA (a plant omega-3), fiber and lignans. Meta-analyses of randomized trials found small reductions in total and LDL cholesterol and in blood pressure with whole or ground seed, and small drops in fasting blood sugar and insulin with whole seed. Flaxseed oil did not lower cholesterol in pooled trials. A placebo-controlled trial found a lignan-rich flaxseed bar did not reduce hot flashes.
Should I use ground or whole flaxseed?
The trials that found effects on cholesterol, blood pressure and blood sugar mostly used ground or milled seed, often baked into foods. Grinding also matters for cyanide: EFSA expects intact linseed to lead to much lower cyanide exposure, while it estimated that 1.3 to 14.7 g of ground linseed with the highest cyanide level in its data, eaten at one time, could reach its short-term limit depending on body weight. NCCIH advises against eating raw or unripe seed.
Does flaxseed oil work as well as ground flaxseed?
Not for cholesterol or blood sugar in the studies cited here. Pooled trials found whole or ground flaxseed lowered LDL cholesterol and fasting blood sugar markers, while flaxseed oil did not, and a 26-week trial of flaxseed oil capsules found no change in LDL. Flaxseed oil supplies ALA but none of the seed's fiber or lignans.
Is Flaxseed / Flaxseed Oil safe, and does it have side effects?
NCCIH states that "limited amounts" of flaxseed or oral flaxseed oil supplements "may be safe" for short-term use (up to 6 months). Bloating, gas, fullness and diarrhea are the common complaints, especially at higher doses. Flaxseed contains cyanogenic glycosides, and EFSA could not exclude a risk for younger age groups from ground linseed with a high cyanide content. NCCIH says flaxseed is possibly unsafe in pregnancy and notes a theoretical interaction with blood thinners, so check with your health care provider first.
What is Flaxseed / Flaxseed Oil?
Flaxseed (linseed) is a rich plant source of alpha-linolenic acid (ALA, a plant omega-3), with USDA data listing about 22.8 g per 100 g of seed, along with lignans (plant compounds thought to have weak estrogen-like effects) and soluble fiber.
Does Flaxseed / Flaxseed Oil interact with any medications?
Possible interactions include: Anticoagulant or antiplatelet drugs (such as warfarin): NCCIH notes theoretical reasons to suspect an interaction; ask your prescriber first. Diabetes medications: whole flaxseed slightly lowered fasting blood sugar and insulin in pooled trials; monitor blood sugar. If you take prescription medication, check with a pharmacist or doctor before using it.
How strong is the scientific evidence for Flaxseed / Flaxseed Oil?
NutraSmarts rates the evidence for Flaxseed / Flaxseed Oil as Strong (4 out of 5). It is backed by 9 study summaries and 14 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.
References(14 citations)
Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.
- Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr. 2009;90(2):288-97. doi: 10.3945/ajcn.2009.27469.PubMedUsed to support: Meta-analysis of 28 randomized trials: flaxseed interventions lowered total and LDL cholesterol by 0.10 and 0.08 mmol/L overall; reductions were significant for whole flaxseed (0.21 and 0.16 mmol/L) and lignan supplements but not flaxseed oil, and larger in postmenopausal women and people with high starting cholesterol. HDL and triglycerides did not change.
- Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013;62(6):1081-9. doi: 10.1161/HYPERTENSIONAHA.113.02094.PubMedUsed to support: Double-blind placebo-controlled trial in 110 patients with peripheral artery disease: foods containing 30 g/day of milled flaxseed for 6 months lowered systolic pressure by about 10 mmHg and diastolic by about 7 mmHg versus placebo, and systolic by 15 mmHg in those starting at 140 mmHg or above. Body weight did not differ between groups.
- Effects of flaxseed supplements on blood pressure: A systematic review and meta-analysis of controlled clinical trial. Clin Nutr. 2016;35(3):615-25. doi: 10.1016/j.clnu.2015.05.012.PubMedUsed to support: Meta-analysis of 15 trials (19 arms, 1302 participants): flaxseed products lowered systolic blood pressure by 2.85 mmHg and diastolic by 2.39 mmHg. The fall was larger in trials of 12 weeks or more. Systolic pressure fell significantly with flaxseed powder but not with oil or lignan extract.
- Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr. 2008;27(1):65-74. doi: 10.1080/07315724.2008.10719676.PubMedUsed to support: Double-blind RCT in 62 adults with high LDL cholesterol: 40 g/day of ground flaxseed in baked goods for 10 weeks, versus wheat bran products, lowered LDL by 13 percent at 5 weeks but not significantly at 10 weeks, lowered Lp(a) by 14 percent and HOMA-IR insulin resistance by 23.7 percent, and lowered HDL in men by 16 percent at 5 weeks. Inflammation and oxidative stress markers did not change.
- A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause. 2012;19(1):48-53. doi: 10.1097/gme.0b013e318223b021.PubMedUsed to support: Phase III randomized double-blind trial in 188 postmenopausal women: a daily bar with 7.5 g flaxseed providing 410 mg lignans for 6 weeks reduced hot flash scores by 4.9 versus 3.5 with a fiber-matched placebo bar (P = 0.29, not significant). Both groups reported bloating, gas, diarrhea and nausea.
- Effect of flaxseed (Linum usitatissimum) supplementation on glycemic control and insulin resistance in prediabetes and type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2022;70:102852. doi: 10.1016/j.ctim.2022.102852.PubMedUsed to support: Meta-analysis of 7 randomized trials of milled or ground flaxseed in adults with prediabetes or type 2 diabetes: small but significant reductions in fasting blood sugar, insulin, HbA1c and HOMA-IR in a fixed-effect model, with heterogeneity for fasting glucose (I2 about 65%). The authors say more trials are needed.
- Seeds, flaxseed (FDC ID 169414). FoodData Central, SR Legacy. FoodData Central. 2019;SR Legacy, published 2019-04-01..SourceUsed to support: USDA food composition database, not PubMed-indexed. Lists 22.8 g of ALA (18:3), 27.3 g of fiber and 18.3 g of protein per 100 g of flaxseed.
- Flaxseed consumption may reduce blood pressure: a systematic review and meta-analysis of controlled trials. J Nutr. 2015;145(4):758-65. doi: 10.3945/jn.114.205302.PubMedUsed to support: Meta-analysis of 11 studies (14 trials): flaxseed lowered systolic blood pressure by 1.77 mmHg and diastolic by 1.58 mmHg; results were not changed by higher baseline blood pressure, and diastolic effects were seen with whole flaxseed and with use for 12 weeks or more.
- Flaxseed supplementation on glucose control and insulin sensitivity: a systematic review and meta-analysis of 25 randomized, placebo-controlled trials. Nutr Rev. 2018;76(2):125-139. doi: 10.1093/nutrit/nux052.PubMedUsed to support: Meta-analysis of 25 randomized placebo-controlled trials: flaxseed lowered fasting glucose (2.94 mg/dL), insulin (7.32 pmol/L) and HOMA-IR (0.49) and raised insulin sensitivity, with no effect on HbA1c. Effects were seen only with whole flaxseed, not flaxseed oil or lignan extract.
- Flaxseed oil supplementation does not affect plasma lipoprotein concentration or particle size in human subjects. J Nutr. 2006;136(11):2844-8. doi: 10.1093/jn/136.11.2844.PubMedUsed to support: Randomized double-blind trial in 56 participants: 3 g/day of ALA from flaxseed oil capsules for 26 weeks did not change LDL, HDL or triglycerides versus olive oil capsules, and adjusted total cholesterol was higher with flaxseed oil. Lipoprotein particle size was unchanged.
- Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr Res. 2013;33(5):367-75. doi: 10.1016/j.nutres.2013.02.012.PubMedUsed to support: Randomized crossover trial in 25 overweight or obese adults with prediabetes: 13 g/day of ground flaxseed for 12 weeks lowered glucose, insulin and HOMA-IR compared with 0 g; 26 g/day did not lower insulin or HOMA-IR. Fructosamine, CRP, adiponectin and IL-6 did not change.
- Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS One. 2007;2(11):e1148. doi: 10.1371/journal.pone.0001148.PubMedUsed to support: Randomized double-blind placebo-controlled crossover trial in 68 adults with type 2 diabetes: 360 mg/day of flaxseed lignan for 12 weeks modestly lowered HbA1c versus placebo (P = 0.001) without changing fasting glucose, insulin, insulin resistance or blood lipids. Urinary enterolignans rose. Funded by Chinese government science grants; the PMC full text states the study capsules were donated by Frutarom Netherlands BV and Jarrow Formulas Inc.
- Evaluation of the health risks related to the presence of cyanogenic glycosides in foods other than raw apricot kernels. EFSA J. 2019;17(4):e05662. doi: 10.2903/j.efsa.2019.5662.PubMedUsed to support: EFSA scientific opinion on cyanogenic glycosides in foods: linseed contains cyanogenic glycosides, and in a human study cyanide release from linseed was slower and less complete than from cassava or bitter almonds. Using the highest level in EFSA's data (407 mg CN/kg), eating 1.3 to 14.7 g of ground linseed in one eating occasion could reach the acute reference dose of 20 micrograms per kg body weight, depending on body weight, and a risk for younger age groups could not be excluded. Intact (not freshly ground) linseed is expected to lead to much lower cyanide exposure.
- Flaxseed and Flaxseed Oil. NCCIH. 2025;Last updated February 2025. Accessed 2026..SourceUsed to support: US government fact sheet, not PubMed-indexed. States that higher doses may cause bloating, fullness and diarrhea, that raw or unripe flaxseed may contain potentially toxic compounds, that some studies suggest flaxseed is possibly unsafe in pregnancy though evidence is not conclusive, that there are theoretical reasons to suspect interactions with anticoagulant or antiplatelet drugs, and that people taking any medicine should talk with a health care provider first.